Trademarkia Logo

Canada

C$
Trademark Search in Canada
MYCB1 & DESIGN

View On IC.GC.CA

MYCB1 & DESIGN
REGISTERED

on 9 Mar 2022

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

MYCB1 GROUP B.V.

Watteaustraat 5 IINL-1077ZHAmsterdam

NL

Serial Number

1936702 filed on 18th Dec 2018

Registration Number

TMA1122638 registered on 9th Mar 2022

Registration expiry Date

9th Mar 2032

Correspondent Address

COASTAL TRADEMARK SERVICES LIMITED

301-543 Granville StreetVancouver

BRITISH COLUMBIA

CA

V6C1X8

MYCB1 & DESIGN

Trademark usage description

nutraceutical products, namely, dietary supplements consisting of cannabidiol (cbd), dietary supplements consisting of trace elements, vitamin and min Read More

Vienna Information

26 . 3 . 4

Several triangles, juxtaposed, joined or intersectingPlusieurs triangles, juxtaposés, accolés ou se coupant

26 . 4 . 1

SquaresCarrés

26 . 4 . 2

RectanglesRectangles

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 7 . 15

Triangles or lines forming an angle with one or more quadrilateralsTriangles ou lignes formant un angle avec un ou plusieurs quadrilatères

Classification Information

Class [005]
Nutraceutical products, namely, dietary supplements consisting of cannabidiol (CBD), dietary supplements consisting of trace elements, vitamin and mineral dietary supplements, dietary supplements for general health and well being, boosting energy, promoting weight loss, relief of pain, reducing inflammation, and treating headache; dietetic sugar for medical use; dietetic sugar substitutes for medical use; biotechnological preparations, namely, medicines for the treatment of infectious diseases and disorders, namely respiratory infections, eye infections, urinary tract infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, blood disorders, pain, inflammation, sepsis, alopecia, cognitive disorders, heart disease, viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, disorders and infections of the endocrine system, namely growth and thyroid disorders, musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, genitourinary diseases and disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, sexual dysfunction, oncological diseases and disorders, liver, gallbladder, and pancreatic diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases, namely, Alzheimer's, Huntington's Disease, and cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, and seizure disorders, gastrointestinal diseases and disorders, dermatological diseases and disorders, namely, dermatitis, eczema, psoriasis, skin pigmentation diseases, psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, autoimmune diseases, for regulating the immune system, for prevention and treatment of cancer, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations, and hormones for medical use

Classification kind code

11

Class [042]
Biotechnological services, namely research and consultancy in the field of biotechnology; development of new biotechnological products for others

Classification kind code

11

Mark Details

Serial Number

1936702

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 2th Mar 2022		Registration Pending
Submitted for opposition 42
on 8th Dec 2021		Advertised
Submitted for opposition 27
on 10th Nov 2021		Approval Notice Sent
Submitted for opposition 26
on 10th Nov 2021		Approved
Submitted for opposition 22
on 27th May 2021		Search Recorded
Submitted for opposition 20
on 27th May 2021		Examiner's First Report
Submitted for opposition 135
on 30th Oct 2020		Amendment to Application
Submitted for opposition 31
on 27th Dec 2018		Formalized
Submitted for opposition 1
on 19th Dec 2018		Created
Submitted for opposition 30
on 18th Dec 2018		Filed